CFN Media recently sat down with MediPharm Labs (TSXV: LABS) CEO Pat McCutcheon. Mr. McCutcheon discusses the company's unique focus on cannabis oils and extracts, MediPharm's cannabis concentrate agreements with other Canadian licensed producers, its advanced facilities and pharmaceutical based approach, the company's revenue model and capabilities, its recent public listing, and MediPharm's roadmap ahead including international plans.